UAE-based Julphar Gulf Pharmaceutical Industries, the largest generic pharmaceutical manufacturer in Middle East and North Africa (Mena), has announced that its board of directors has appointed Jerome Carle as the company's general manager.

The board expressed confidence in Carle’s aptitude and competence to make an immediate impact to the business, to lead the management team and to execute the company’s strategic objectives, said a statement.

The Julphar roadmap – Vision 2020 – will be a key pillar to drive Julphar to the top of the Mena markets, it said.

Carle joined Julphar in January 2017 as chief financial officer. He has over 20 years of financial expertise in emerging markets and his broad experience has shown his ability to deliver results in challenging environments.

He has a proven track-record in the pharmaceutical industry, having served in the most reputable multi-national companies, with a full hand responsibility on the business operations, financials and administration.

Carle said: “I am very pleased, honoured and humbled to have been appointed to this role, and I would like to thank the members of the Board for their trust.”

“I am thrilled to serve a company that makes a real difference in patients and consumers’ quality of life. Julphar is uniquely positioned in the Middle East and African (MEA) markets to improve the healthcare system and I am proud to play a role in achieving our company’s mission,” he added. – TradeArabia News Service